Investor Assenagon Asset Management S.A.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Assenagon Asset Management S.A. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-01-18 13G CBIO / Crescent Biopharma, Inc. 1,114,604 1,876,898
2022-01-18 13G CBIO / Crescent Biopharma, Inc. 1,114,604 0
2021-11-24 13G NERV / Minerva Neurosciences, Inc. 1,385,491
2021-11-24 13G NERV / Minerva Neurosciences, Inc. 6,081,312
2020-08-06 13G CBIO / Crescent Biopharma, Inc. 1,114,604 1,114,604
2020-08-04 13G PI / Impinj, Inc. 1,367,396 1,176,207
2020-06-24 13G LC / LendingClub Corporation 3,747,271
2020-06-19 13G CBIO / Crescent Biopharma, Inc. 1,114,604
2020-06-17 13G AFMD / Affimed N.V. 4,980,118 779
2020-06-16 13G AFMD / Affimed N.V. 4,980,118
2020-04-17 13G MX / Magnachip Semiconductor Corporation 2,393,052
2019-05-08 13G PI / Impinj, Inc. 1,367,396
2019-05-08 13G/A PI / Impinj, Inc. 648,796